Abstract -The prevalence of hepatitis C vims (HCV) antibody was determined in 130 patients with alcoholic liver disease using a second-generation anti-HCV enzyme immunoassay (ELISA 2) and confirmed by a sensitive polymerase chain reaction procedure measuring HCV RNA. Hepatic disease was evaluated by clinical and biochemical studies and, whenever possible, by liver biopsy. Seventy-one patients were diagnosed as having cirrhosis, and 59 alcoholic hepatitis (n = 33) or fatty liver (n = 26). The prevalence of anti-HCV in the total group was 9.2% and did not differ significantly in the cirrhotics (11.3%) as compared with the non-cirrhotics (6.8%). HCV RNA was detected in six out of eight cirrhotics and three out of four non-cirrhotics who were ELISA 2 positive. A positive test for antibodies to hepatitis core antigen (anti-HBc) was more frequent in anti-HCV-positive patients (75%) than in the anti-HCV-negative group (14%, P< 0.001). Anti-HBc was also found more frequently in the cirrhotics (25.4%) than in the alcoholics without cirrhosis (11.9%). However, the prevalence of hepatitis B surface antigen was equally low in both groups (cirrhotics 1.4%, non-cirrhotics 1.7%). No correlation was observed between the prevalence of anti-HCV antibodies and the severity of liver dysfunction. These results indicate that HCV, and especially HCV-viraemia, is less frequent in alcoholics in southern Germany than suspected in previous studies, and that the prevalence of HCV markers in alcoholics has been overestimated by ELISA 1 used alone.
INTRODUCTION
Following the development of the first assay for the detection of hepatitis C virus (HCV) antibodies, studies on patients with alcohol-related liver diseases performed in numerous countries, revealed a relatively high prevalence of anti-HCV antibodies (Pares etai, 1990; Brillanti et al., 1991; Caldwell et al., 1991; Nalpas et al., 1992) . In an earlier study using a first-generation HCV-ELISA (C-100) we found a similarly high percentage of positive anti-HCV tests in patients with alcoholic cirrhosis (Bode et al., 1991) . However, since a highly significant correlation was found between the gamma-globulin concentration and the titre of reactivity for anti-HCV, we assumed that many of these reactions were false-positives similar to those described in patients with autoimmune chronic active hepatitis (McFarlane et al., 1990) . Since no confirmatory test was performed, this assumption remained speculative.
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In an attempt to clarify the question as to the incidence of HCV infection in patients with alcoholic liver disease in our region, we prospectively investigated the prevalence of anti-HCV in 130 consecutive patients using a second-generation ELISA, and checked positive findings by determining HCV RNA, a marker of HCV multiplication, by the polymerase chain reaction (PCR). The patients' sera were also tested for hepatitis B surface-antigen (HBs-Ag) and antibodies to hepatitis core antigen (anti-HBc).
PATIENTS
One hundred and thirty consecutive patients with a history of chronic alcohol abuse admitted to our department were investigated. The patients had a mean daily alcohol consumption of >80g/day for >4 years. Seventy-one were suffering from alcoholic cirrhosis, which was confirmed by liver biopsy and/or laparoscopy in 41. In another three of the 41 patients, the diagnosis of cirrhosis was established by laparoscopy alone. In 13 of the latter patients a detailed histology report was not available because the laparoscopy or biopsy was performed in another hospital. In the remaining 30 cirrhotics the diagnosis was based on typical clinical findings (hepatosplenomegaly, ascites, oesophageal varices) and laboratory results. Liver biopsy or laparoscopy could not be performed in the latter group either because of severe coagulation disorders or because liver biopsy was refused. Of the 59 alcoholics without cirrhosis 12 had alcoholic hepatitis proven by liver biopsy; the remaining 47 patients refused liver biopsy or left the hospital before biopsy could be performed. They were diagnosed as having at least fatty liver on the basis of typical ultrasound findings. Twenty-one of these 47 patients might be diagnosed as having mild to moderate alcoholic hepatitis on the basis of the laboratory results (serum bilinibin values above 1.5 mg/dl and aspartate transaminase activity more than twice the upper level of normalcy). Cirrhosis seemed unlikely in these patients since there was absence of clinical and ultrasound findings or laboratory results suggestive of advanced liver disease (clinical criteria: absence of ascites, oedema, a palpable spleen or visible collaterals on the abdomen; ultrasound criteria: absence of suspicious liver margin, ascites or signs of portal hypertension; biochemical criteria: serum albumin concentration above 3 g/dl and prothrombin index above 70% of normal values). In addition, 30 of the 47 non-cirrhotic patients revealed no oesophageal varices on endoscopy performed because of abdominal pain or other symptoms. Data on age, sex-distribution, clinical findings and laboratory values are shown in Table 1 .
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This study was approved by the Clinical Investigation Committee of the Robert-Bosch Hospital; all patients gave their informed consent to participate in the study.
METHODS
Blood was sampled for routine laboratory tests including serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (gamma-GT), total bilinibin, albumin, gamma-globulin and prothrombin index. Tests for HBs-Ag and anti-HBc were performed by solid-phase radioimmunoassay (Abbott Laboratories, Wiesbaden, Germany) and the results were expressed in accordance with the manufacturer's specifications. Anti-HCV was tested for using a second-generation anti-HCV test (Abbott HCV ELISA second-generation). Serum samples were coded and stored at -20°C. The sera were tested weekly in accordance with the manufacturer's instructions. The person who did the tests had no prior knowledge of either the clinical or laboratory findings in the patients. Results were read at 492 nm using a Behring ELISA plate reader (Behring AG Marburg, Germany).
Positive results were confirmed in all cases by re-testing in duplicate, as recommended by the manufacturer.
For determination of HCV RNA (Seelig et al., 1993) 500-nl samples were concentrated by ultracentrifugation through a sucrose cushion (Beckman TL 60; 40000 r.p.m., 60 min, 4°C) followed by RNA extraction. Sediments were dissolved in 100 \i\ of lysis buffer (2% SDS, 10 mM Tris-HCl, pH 7.5,1 mM EDTA, 10 ug proteinase K, 0.1 ug tRNA), incubated for 2h at 55°C followed by two organic extractions (phenol/chloroform and chloroform only) and ethanol precipitation. The RNA pellets were dissolved in 20 |il of a solution containing 50 U RNase inhibitor (RNasin, Promega, Woods, WI, USA) and 1 mM dithiothreitol, divided into two 10 ul aliquots one of which was stored at -80°C and the other used directly for cDNA synthesis. The RNA solution was heated to 80°C (1 min) and chilled on ice (2 min), and synthesis of cDNA was effected for 60 min at 45°C with Moloney murine leukaemia virus reverse transcriptase (10 U) in the presence of 5 mM Tris-HCl, pH 8.5, 50 mM KCI, 2.5 mM MgCl 2 , 1 mM of dNTPs, 20 pmol of first-round primers (nt -321 to -292) GACACTCCAC-CATAGATCACTCCCCTGTGA, (nt -29 to -58) CACTCGCAAGCACCCTATCAGGCA-GTACCA, and 50 U of RNasin in a volume of 20 ul. After the addition of water (50 ul) the cDNA was denatured by heat (98°C, 3 min) and amplified by PCR in the first round in a final volume of 100 u.1 containing 10 mM Tris-HCl, pH8.4, 50 mM KCI, 2.5 mM MgCl 2 , 0.2 mM of the four dNTPs, 2 U of Taq DNA polymerase with the temperature-time profile 93°C/1 min, 50°C/2 min; 72°C/2 min for 37 cycles. A volume of 10 \i[ of the first-round PCR was amplified similarly in a second PCR with an internal pair of primers (nt-298 to -274) CCTGTGAGGAACTAC-TGTCTTCACG, (nt -52 to -75) AGTAC-CACAAGGCCTTTCGCGACC.
Histological work-up of the liver biopsies was carried out by a pathologist who was unaware of the clinical and laboratory findings. The diagnosis of alcoholic liver disease and chronic hepatitis was based on established criteria (Bianchi et al., 1977; International group, 1981) .
In statistical analyses values were expressed as means (±SD). Comparisons between groups were made using the Wilcoxon test, as required.
RESULTS
HCV-antibodies were detected in 12 out of 130 patients (9.2%). The prevalence of anti-HCV was slightly higher in the subgroup with cirrhosis than in the subgroup of patients with alcoholic hepatitis or fatty liver (Table 2) , whereas there was hardly any difference in the percentage of anti-HCVpositive results between patients with alcoholic hepatitis and those with fatty liver (Table 2) . Three of the 12 anti-HCV-positive patients were found to have risk factors for HCV infection (par- enteral drug abuse and numerous different sexual partners in three, repeated tattooing in one). No such risk factors were identified for the remaining nine patients.
On PCR, HCV RNA was detected in nine out of 12 anti-HCV-positive patients. The percentage of HCV RNA did not differ significantly between the subgroups investigated ( Table 2) .
Nearly 20% of the total group of alcoholic patients were positive for anti-HBc (Table 2) . However, only two patients were HBs-Ag positive. Anti-HBc-positive results were obtained significantly more frequently in the anti-HCVpositive patients (75%) than in those who were anti-HCV negative (Table 3) .
The frequency of episodes of upper gastrointestinal bleeding or operations in the history did not differ significantly between the anti-HCVpositive and the anti-HCV-negative groups (Table  3) . Anti-HCV-positive patients had higher ALT values, lower AST: ALT quotients, and distinctly lower mean values for gamma-GT than those patients without anti-HCV (Table 3) . Table 4 summarizes the histological findings in those HCV RNA-positive and HCV RNAnegative subjects for whom biopsies were available. All HCV RNA-positive patients were found to have cirrhosis, the percentage with mixed micro-macronodular cirrhosis being larger than in HCV RNA-negative patients. Histological changes compatible with chronic active hepatitis were found in two of the five HCV RNA-positive patients.
DISCUSSION
In the present study, the percentage of anti-HCV-positive patients was appreciably lower than in a previous investigation of a comparable group of patients with alcohol-related liver disease, in whom an anti-HCV test of the first generation was employed (Bode et al., 1991) . This applies both to the overall group, and to the group of patients with cirrhosis (previous study: 38.5% positive). The percentage of positive anti-HCV results was distinctly lower, despite the reportedly higher sensitivity of the second-generation anti-HCV ELISA, as found in studies on patients with nonalcoholic liver disease (Alter, 1992; Jeffers et al., 1992) . The present findings provide support for the suspicion, expressed earlier (Bode et al, 1991) , that a large percentage of the figures obtained with the anti-HCV ELISA of the first generation were false-positives. As first shown in patients with autoimmune hepatitis (Caldwell et al, 1991) , the false-positive findings obtained with the first-generation anti-HCV ELISA in patients with alcoholic liver disease are probably due to high immunoglobulin concentrations in the serum (Bode etal., 1991) .
The present results suggest -as also in some other studies involving patients with alcoholic liver disease in which anti-HCV antibodies were determined using a first-generation ELISA -that the percentage of positive findings has been overestimated. This applies to studies both from Europe (Poynard et al., 1991; Laskus et al., 1992) and from the USA (Caldwell et al, 1991; Mendenhall et al, 1991) . In a numerically large study from the USA involving stored sera of patients with alcoholic liver disease, determinations using a first-generation anti-HCV ELISA revealed positive findings in 27%, while a retest of some of the sera with a first-generation recombinant immunoblot assay (RIBA) resulted in a reduction in positive findings by almost 80% (Mendenhall et al, 1991) . In other studies, too, an appreciable decrease (30-40%) in HCV-positive findings in patients with alcoholic liver disease was observed when retesting was done with a RIBA (Lampertico et al, 1991; Laurent-Puig et al, 1992; Nalpas etal, 1992) .
Also, when additional confirmatory tests (firstand second-generation RIBA) are employed, marked differences in the prevalence of anti-HCV-positive findings are found in studies from the same region. Thus, for example, from France, prevalence figures of 5.3% (Laurent-Puig et al, 1992) and 36% (Nalpas et al., 1992) have been reported. Further studies will have to be carried out to determine whether these discrepancies are due in the first instance to specific patient selection, or to geographical differences in HCV prevalence. The latter are considered responsible for the high percentage of anti-HCV-positive findings in patients with alcoholic cirrhosis reported from Spain (Pares et al, 1990 ), Italy (Brellanti et al, 1991 , France (Poynard et al, 1992) and in particular Japan, where the majority of alcoholics with chronic liver disease present with the clinical picture of chronic viral hepatitis, and where the typical picture of alcoholic hepatitis is relatively rare (Nishiguche et al, 1991; Ishii et al, 1992; Takadaefa/., 1992) .
Although the percentage of anti-HCV-positive results in the overall group (9.2%) was distinctly lower than in a previous study performed in a similar group of patients (Bode et al, 1991) , the prevalence was more than 10 times as high as in a general population, such as blood donors (Prohaska et al., 1992) . The reason for this appreciably higher prevalence of HCV infection in patients with alcohol-related liver disease is not clear. A risk factor for the transmission of infection was identified in only three of the anti-HCVpositive patients. The fact that nine of the 12 anti-HCV-positive alcoholics were also found to be anti-HBC positive does, however, suggest that, at least in some of these patients, such risk factors as sexual promiscuity or intravenous drug abuse were present, but not admitted when the history was taken.
In contrast to reports by other authors (Pares etal, 1990) , the present study revealed no significant correlation between the prevalence of anti-HCV antibodies or HCV RNA and the severity of liver dysfunction. It must, however, be taken into account that the percentage of patients with severe liver dysfunction in our own investigation is relatively small. This applies in particular to the patients in the alcoholic hepatitis group, for most of whom the diagnosis was made on the basis of laboratory findings and clinical examination.
The small number of HCV RNA-positive patients for whom liver biopsy material was available does not permit a definitive statement to be made on the histological findings. Two of the five patients had findings compatible with alcoholinduced cirrhosis. This finding is in accord with the observation of others (Nalpas et al, 1992) that an asymptomatic HCV carrier state may exist in alcoholics. Only in two patients did the histological findings indicate chronic viral hepatitis.
It has been known for more than a decade 
